Cargando…

Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort

OBJECTIVE: COVID-19 survivors are at risk for long-term health effects, but assessing the sequelae of COVID-19 at large scales is challenging. High-throughput methods to efficiently identify new medical problems arising after acute medical events using the electronic health record (EHR) could improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerchberger, Vern Eric, Peterson, Josh F, Wei, Wei-Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452157/
https://www.ncbi.nlm.nih.gov/pubmed/36005898
http://dx.doi.org/10.1093/jamia/ocac159
_version_ 1784784870174621696
author Kerchberger, Vern Eric
Peterson, Josh F
Wei, Wei-Qi
author_facet Kerchberger, Vern Eric
Peterson, Josh F
Wei, Wei-Qi
author_sort Kerchberger, Vern Eric
collection PubMed
description OBJECTIVE: COVID-19 survivors are at risk for long-term health effects, but assessing the sequelae of COVID-19 at large scales is challenging. High-throughput methods to efficiently identify new medical problems arising after acute medical events using the electronic health record (EHR) could improve surveillance for long-term consequences of acute medical problems like COVID-19. MATERIALS AND METHODS: We augmented an existing high-throughput phenotyping method (PheWAS) to identify new diagnoses occurring after an acute temporal event in the EHR. We then used the temporal-informed phenotypes to assess development of new medical problems among COVID-19 survivors enrolled in an EHR cohort of adults tested for COVID-19 at Vanderbilt University Medical Center. RESULTS: The study cohort included 186 105 adults tested for COVID-19 from March 5, 2020 to November 1, 2021; of which 30 088 (16.2%) tested positive. Median follow-up after testing was 412 days (IQR 274–528). Our temporal-informed phenotyping was able to distinguish phenotype chapters based on chronicity of their constituent diagnoses. PheWAS with temporal-informed phenotypes identified increased risk for 43 diagnoses among COVID-19 survivors during outpatient follow-up, including multiple new respiratory, cardiovascular, neurological, and pregnancy-related conditions. Findings were robust to sensitivity analyses, and several phenotypic associations were supported by changes in outpatient vital signs or laboratory tests from the pretesting to postrecovery period. CONCLUSION: Temporal-informed PheWAS identified new diagnoses affecting multiple organ systems among COVID-19 survivors. These findings can inform future efforts to enable longitudinal health surveillance for survivors of COVID-19 and other acute medical conditions using the EHR.
format Online
Article
Text
id pubmed-9452157
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-94521572022-09-09 Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort Kerchberger, Vern Eric Peterson, Josh F Wei, Wei-Qi J Am Med Inform Assoc Research and Applications OBJECTIVE: COVID-19 survivors are at risk for long-term health effects, but assessing the sequelae of COVID-19 at large scales is challenging. High-throughput methods to efficiently identify new medical problems arising after acute medical events using the electronic health record (EHR) could improve surveillance for long-term consequences of acute medical problems like COVID-19. MATERIALS AND METHODS: We augmented an existing high-throughput phenotyping method (PheWAS) to identify new diagnoses occurring after an acute temporal event in the EHR. We then used the temporal-informed phenotypes to assess development of new medical problems among COVID-19 survivors enrolled in an EHR cohort of adults tested for COVID-19 at Vanderbilt University Medical Center. RESULTS: The study cohort included 186 105 adults tested for COVID-19 from March 5, 2020 to November 1, 2021; of which 30 088 (16.2%) tested positive. Median follow-up after testing was 412 days (IQR 274–528). Our temporal-informed phenotyping was able to distinguish phenotype chapters based on chronicity of their constituent diagnoses. PheWAS with temporal-informed phenotypes identified increased risk for 43 diagnoses among COVID-19 survivors during outpatient follow-up, including multiple new respiratory, cardiovascular, neurological, and pregnancy-related conditions. Findings were robust to sensitivity analyses, and several phenotypic associations were supported by changes in outpatient vital signs or laboratory tests from the pretesting to postrecovery period. CONCLUSION: Temporal-informed PheWAS identified new diagnoses affecting multiple organ systems among COVID-19 survivors. These findings can inform future efforts to enable longitudinal health surveillance for survivors of COVID-19 and other acute medical conditions using the EHR. Oxford University Press 2022-08-25 /pmc/articles/PMC9452157/ /pubmed/36005898 http://dx.doi.org/10.1093/jamia/ocac159 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com https://academic.oup.com/pages/standard-publication-reuse-rightsThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
spellingShingle Research and Applications
Kerchberger, Vern Eric
Peterson, Josh F
Wei, Wei-Qi
Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort
title Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort
title_full Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort
title_fullStr Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort
title_full_unstemmed Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort
title_short Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort
title_sort scanning the medical phenome to identify new diagnoses after recovery from covid-19 in a us cohort
topic Research and Applications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452157/
https://www.ncbi.nlm.nih.gov/pubmed/36005898
http://dx.doi.org/10.1093/jamia/ocac159
work_keys_str_mv AT kerchbergerverneric scanningthemedicalphenometoidentifynewdiagnosesafterrecoveryfromcovid19inauscohort
AT petersonjoshf scanningthemedicalphenometoidentifynewdiagnosesafterrecoveryfromcovid19inauscohort
AT weiweiqi scanningthemedicalphenometoidentifynewdiagnosesafterrecoveryfromcovid19inauscohort